Journal: Journal of Medicinal Chemistry
Article Title: Development of High-Affinity CHD1 Chromodomain Inhibitors
doi: 10.1021/acs.jmedchem.5c03690
Figure Lengend Snippet: Target engagement and selectivity of CHD1 tCD ligands. (A) Further extension of 2n to mimic click-chemistry modification ( 2r and 2s ) for the generation of a TAMRA probe. IC 50 and K d values for compound binding to the CHD1 tCD are listed. (B) Crystal structure of the CHD1 tCD/ 2s complex (PDB code 9T9I ). The electron density of the ligand was contoured at 1.0 σ. (C) Displacement of 2s-TAMRA from nanoluciferase (NLuc)–CHD1 tCD by 2s in transfected HEK293T cells determined by NanoBRET assay. (D) Inhibition of binding of full-length CHD1 to a LSD1-K114me3 peptide by 2n . A biotinylated LSD1-K114me3 peptide was immobilized on streptavidin sepharose beads and incubated with HEK293T cell extract treated with the indicated concentrations of 2s or DMSO vehicle control. Bound CHD1 was detected by Western blot. Relative, normalized signal intensities are indicated. (E) Inhibition of catalytic activity of the indicated epigenetic enzymes by 2n and 2s at 10 μM was determined by activity assays described in the . (F) Inhibition of H3K4me3 peptide binding to the reader domains of TAF3, SPIN1, or PHF8 by 2n and 2s (at 16 μM) determined by FRET assay. (G, H) Cell viability of PC-3M-Luc (G) and 22Rv1 ( H ) cells after 48 h treatment with 2n or 2s determined by MTT assay. ( I – K ) Proliferation of PC-3M-Luc (I), LNCaP-Luc (J), and 22Rv1 (K) cells upon treatment with two different siRNAs directed against CHD1 (siCHD1–1 and siCHD1–2) or control siRNA (siCtrl). Knockdown efficiencies are shown in Figure S8J .
Article Snippet: Membranes (Immobilon-P, Millipore) were blocked for 1 h in PBS buffer supplemented with 0.1% Tween 20 and 5% (w/v) skim milk (1h rt), decorated with anti-CHD1 antibody (BETHYL, A301–218A, 1:2500) at 4 °C overnight, and then decorated with mouse anti-rabbit IgG-HRP secondary antibody (Cell Signaling, 5127, 1:10,000) for 45 min at rt.
Techniques: Drug discovery, Modification, Binding Assay, Transfection, Inhibition, Incubation, Control, Western Blot, Activity Assay, MTT Assay, Knockdown